CTOs on the Move


 
UNAVCO is a Boulder, CO-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.unavco.org
  • 6350 Nautilus Dr
    Boulder, CO USA 80301
  • Phone: 303.381.7500

Executives

Name Title Contact Details

Similar Companies

Digital Time Capture

Digital Time Capture Inc. is a Edmonton, AB-based company in the Software and Internet sector.

Axonify

Axonify is the world`s first Employee Knowledge Platform. It combines an award-winning approach to microlearning, with innovative knowledge-on-demand capabilities and the entire experience is gamified, driving high levels of participation.

MyHealthFunds

MyHealthFunds, LLC is a Monument, CO-based company in the Software and Internet sector.

Vineti

Vineti is a company purpose-built for personalized therapies. From the beginning, Vineti`s founders have understood the challenges that biotech and pharmaceutical innovators face in developing personalized therapies. The emerging ecosystem of cell therapies, gene therapies, and personalized cancer vaccines requires new enabling technologies to align and manage production processes and the patient journey. Our patent pending Personalized Therapy Management (PTM) platform provides the next-generation technology that advanced therapies need.

Cypher Genomics

Cypher Genomics is a leading genome informatics company offering a highly accurate, rapid and robust interpretation software solution for users of human genome sequencing. The proprietary, automated genomic interpretation platform allows clinical laboratories to tune Cypher Genomics' market leading sensitivity and specificity profiles to develop molecular tests for diagnostic and prognostic use, and pharmaceutical companies to discover biomarkers from whole genome sequence data in sample sizes typical of early stage drug development studies. Through Mantis™, the genome interpretation software as a service offering, and Coral™, a biomarker discovery service, Cypher Genomics can improve health care and reduce costs by facilitating improved diagnostic accuracy and earlier interventions, optimizing therapeutic approaches and reducing adverse drug reactions. The gap between the ability to generate whole genome sequences at scale and the primarily manual process of interpretation to date creates a significant unmet need that is well served by the Cypher Genomics solution.